Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 4 (April)

1. HLA-B8 association with late-stage melanoma--an immunological lesson?
   BMC Med, 4: 5. [Abstract] [Full-text]
2. cDNA-array profiling of melanomas and paired melanocyte cultures.
   J Cell Physiol, 207(3): 697-705. [Abstract] [Full-text]
3. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
   J Natl Cancer Inst, 98(7): 472-82. [Abstract] [Full-text]
4. A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.
   Oncogene, 25(15): 2160-9. [Abstract] [Full-text]
5. Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.
   Blood, 107(8): 3153-60. [Abstract] [Full-text]
6. Extended follow-up of small melanocytic choroidal tumors treated with transpupillary thermotherapy.
   Arch Ophthalmol, 124(4): 503-6. [Abstract] [Full-text]
7. Novel biomarkers in malignant melanoma.
   Clin Chim Acta, 367(1): 28-35. [Abstract] [Full-text]
8. Population exposure to ultraviolet radiation in Finland 1920-1995: Exposure trends and a time-series analysis of exposure and cutaneous melanoma incidence.
   Environ Res, 101(1): 123-31. [Abstract] [Full-text]
9. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
   Arch Otolaryngol Head Neck Surg, 132(4): 370-3. [Abstract] [Full-text]
10. Recent tanning bed use: a risk factor for melanoma.
    Arch Dermatol, 142(4): 485-8. [Abstract] [Full-text]
11. Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors.
    Arch Dermatol, 142(4): 471-6. [Abstract] [Full-text]
12. Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma.
    Arch Dermatol, 142(4): 447-52. [Abstract] [Full-text]
13. Multiple primary melanoma: two-year results from a population-based study.
    Arch Dermatol, 142(4): 433-8. [Abstract] [Full-text]
14. Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma.
    J Invest Dermatol, 126(5): 980-5. [Abstract] [Full-text]
15. Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.
    Exp Cell Res, 312(8): 1401-17. [Abstract] [Full-text]
16. Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?
    Int J Cancer, 119(1): 157-61. [Abstract] [Full-text]
17. Presentation and detection of invasive melanoma in a high-risk population.
    J Am Acad Dermatol, 54(5): 783-92. [Abstract] [Full-text]
18. A retrospective cohort study of Southeast Asian patients with large congenital melanocytic nevi and the risk of melanoma development.
    J Am Acad Dermatol, 54(5): 778-82. [Abstract] [Full-text]
19. Large or multiple congenital melanocytic nevi: occurrence of neurocutaneous melanocytosis in 1008 persons.
    J Am Acad Dermatol, 54(5): 767-77. [Abstract] [Full-text]
20. Metastatic melanoma to lymph nodes in patients with unknown primary sites.
    Cancer, 106(9): 2012-20. [Abstract] [Full-text]
21. Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy.
    Cancer, 106(9): 2005-11. [Abstract] [Full-text]
22. Reconstruction following radical resection of recurrent metastatic axillary melanoma.
    Plast Reconstr Surg, 117(5): 1576-83. [Abstract] [Full-text]
23. Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up period.
    Cancer Imaging, 6: 24-9. [Abstract] [Full-text]
24. Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells.
    Cancer Chemother Pharmacol, 58(2): 195-202. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.